Onviz Oral Drops

Introduction

Onviz is a prescription medication that contains the active ingredient Ondansetron. It is available under the brand name Onviz. This medication is primarily used to prevent nausea and vomiting associated with certain medical conditions and treatments.

Uses

Onviz are commonly prescribed to manage nausea and vomiting caused by chemotherapy, radiation therapy, and surgery. It is also used to prevent nausea and vomiting associated with certain medications, such as opioids.

Dosage and Administration

Onviz should be used as directed by your healthcare provider. The dosage may vary depending on the individual’s age, weight, and the severity of symptoms. Typically, the recommended dose for adults is 8 mg taken orally 30 minutes before chemotherapy or radiation therapy. For children, the dose is based on their body weight.

The drops can be taken with or without food. If you are using the drops, carefully measure the prescribed amount using the provided dropper and mix it with a small amount of liquid before administration. Follow your healthcare provider’s instructions regarding dosage and administration.

Mechanism of Action

Ondansetron, the active ingredient in Onviz, belongs to a class of medications known as selective 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a chemical in the brain that can trigger nausea and vomiting. By inhibiting the effects of serotonin, Ondansetron helps to prevent and relieve nausea and vomiting.

Side Effects

Common side effects may include headache, dizziness, constipation, and fatigue. These side effects are generally mild and temporary.

However, there can be serious side effects associated with the use of Ondansetron. Seek medical attention immediately if you experience any of the following: irregular heartbeat, chest pain, severe dizziness, or allergic reactions such as rash, itching, or swelling.

Drug Interactions

Onviz may interact with certain medications, increasing the risk of side effects or reducing the effectiveness of either medication. Inform your healthcare provider about all the medications you are currently taking, including prescription, over-the-counter, and herbal products.

Some medications that may interact with Onviz include apomorphine, tramadol, and certain antidepressants. Your healthcare provider can provide more specific information on potential drug interactions.

Precautions

Before using Onviz, inform your healthcare provider about any known allergies, medical conditions, or medications you are currently taking. This will help ensure that the medication is safe and appropriate for you.

Onviz should be used with caution in individuals with a history of heart conditions, liver problems, or electrolyte imbalances. Follow your healthcare provider’s instructions and report any new or worsening symptoms.

Storage

Onviz should be stored at room temperature, away from direct sunlight and moisture. Keep the medication out of the reach of children and pets. Do not use the drops if they are past the expiration date.

Patient Tips

• Follow the dosage instructions provided by your healthcare provider.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular schedule.
• If you experience any side effects or have concerns about the medication, contact your healthcare provider.
• Do not stop taking Onviz without consulting your healthcare provider.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Ondansetron 2 mg/ml Solution for Injection (Health Professionals SmPC) Available at:
• Ondansetron (Drugs.com) [Accessed 3 Jun. 2024] (online) Available at:
• ondansetron (pf) in dextrose piggyback (RX) [Accessed 19 Jun. 2024] (online) Available at:
• Ondansetron Injection (MedlinePlus) [Accessed 2 Jun. 2024] (online) Available at:
• Roila F, Del Favero A. Ondansetron clinical pharmacokinetics. Clin Pharmacokinet. 1995 Aug;29(2):95-109. doi: 10.2165/00003088-199529020-00004. [Accessed 15 Jun. 2024] Available at: